Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-22-000112

SVP and CFO acquired 1,833 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lamothe Jeffrey G. SVP and CFO 2022-01-29 Option exercise +1,833 7,192 D
Derivatives
Lamothe Jeffrey G. SVP and CFO 2022-01-29 Option exercise · Restricted Stock Unit +1,833 3,667 D
Loading xslF345X03/lamothe.xml…